Abstract: Objective To investigate the correlation between serum chemerin level and non-alcoholic fatty liver
disease (NAFLD). Methods A total of 56 patients with NAFLD and 60 health controls with normal glucose
tolerance in the First Hospital of Qinhuangdao from June 2015 to August 2016 were selected. The levels of
serum chemerin, hemoglobin A 1C (HbA 1C ), homeostasis model assessment-insulin resistance index (HOMA-
IR), triglyceride (TG), high density lipoprotein cholesterol (HDL-C), body mass index (BMI) and waist-to-hip
ratio (WHR) were tested and compared. Pearson anlysis was used to analyze the correlation between serum
chemerin and the above indexes and multiple linear regression was employed to explore the influence factors
of serum chemerin level. Results The serum chemerin levels of patients in NAFLD group were significantly
higher than those of the control group [(79.71 ± 10.36) nmol/ml vs (62.43 ± 11.92) nmol/ml; t = 8.308, P <
0.001]. The levels of serum chemerin were positively correlated with BMI, WHR, HbA 1C , LgHOMA-IR and
TG (r = 0.382, 0.517, 0.442, 0.590, 0.295; P < 0.05), and were negatively correlated with HDL-C (r = -0.314,
P = 0.003). Multiple linear regression analysis showed that HbA 1C , LnHOMA-IR and WHR were the influence
factors of serum chemerin level (P < 0.001). Conclusions Patients with NAFLD have higher level of serum
chemerin, HOMA-IR, HbA 1C and WHR are key indicators of serum chemerin, suggesting that chemerin may
be closely associated with non-alcoholic fatty liver disease.
|